Clinical Trial - Trial jRCT2051230090
Access comprehensive clinical trial information for jRCT2051230090 through Pure Global AI's free database. This phase not specified trial is sponsored by sponsor not specified and is currently Not yet recruiting. The study focuses on Parkinson's disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCT2051230090
Not yet recruiting
Trial Details
Japan Registry Clinical Trial • jRCT2051230090
Untitled Trial
Phase 2 randomized double blind controlled study to investigate disease modifying effect, safety and optimal dose of oral semaglutide tablet for patients with Parkinson's disease (MOST ABLE study)
Study Focus
Interventional
Sponsor & Location
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Parkinson disease
Parkinsonism in diseases classified elsewhere
Dementia in Parkinson disease
Secondary parkinsonism
Postencephalitic parkinsonism
Data Source
Japan Registry Clinical Trial
jRCT2051230090
Non-Device Trial